Visualising microglial activation in vivo

GLIA

Volumn 40, Issue 2, 2002, Pages 206-217

  Banati, Richard B ^a,b  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Inflammation; Mitochondrial benzodiazepine receptor; Neurodegeneration; Neuroimaging

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CARBON; DIAGNOSTIC AGENT; ISOQUINOLINE DERIVATIVE; LIGAND; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL; BINDING SITE; BRAIN DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENCEPHALITIS; HUMAN; METABOLISM; MICROGLIA; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW;

ANIMALS; BINDING SITES; BRAIN DISEASES; CARBON RADIOISOTOPES; ENCEPHALITIS; HUMANS; ISOQUINOLINES; LIGANDS; MAGNETIC RESONANCE IMAGING; MICROGLIA; MITOCHONDRIA; PREDICTIVE VALUE OF TESTS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036850086     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10144     Document Type: Review

References (72)

1. Alho H, Varga V, Krueger KE. 1994. Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: Relation to cell growth. Cell Growth Differ 9:1005-1014.
2. Anholt RR, Pedersen PL, DeSouza EB, Snyder SH. 1986. The peripheral-type benzodiazepine receptor. Localisation to the mitochondrial outer membrane. J Biol Chem 261:776-783.
3. Banati RB, Graeber MB. 1994. Surveillance, intervention and cytotoxicity: Is there a protective role of microglia? Dev Neurosci 16:114-127.
4. Banati RB, Gehrman J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7:111-118.
5. Banati RB, Myers R, Kreutzberg GW. 1997. PK ("peripheral benzodiazepine")-binding sites in the CNS indicate early and discrete brain lesions: Microautoradiographic detection of [3H] PK11195 binding to activated microglia. J Neurocytol 26:77-82.
6. Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, Brooks DJ, Jones T, Duncan JS. 1999. [11C](R)-PK11195 PET-imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 53:2199-2203.
7. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R. 2000. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123:2321-2337.
8. Banati RB, Cagnin A, Brooks DJ, Gunn RN, Myers R, Jones T, Birch R, Anand P. 2001. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. NeuroReport 12:3439-3442.
9. Beach TG, Woodhurst WB, Jones MW, MacDonald DB. 1995. Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett 191:27-30.
10. Benavides J, Cornu P, Dennis T, Dubois A, Hauw J-J, MacKenzie ET, Sazdovitch V, Scatton B. 1988. Imaging of human brain lesions with a w3 site radioligand. Ann Neurol 24:708-712.
11. Blahos J, Whalin ME, Krueger KE. 1995. Identification and purification of a 10-kilodalton protein associated with mitochondrial benzodiazepine receptors. J Biol Chem 270:20285-20291.
12. Cagnin A, Myers R, Gunn RN, Turkheimer FE, Cunningham VJ, Brooks DJ, Jones T, Banati RB. 2001a. Imaging activated microglia in the ageing human brain. In: Gjedde A, Hansen SB, Knudsen GM, Paulson OB, editors. Physiological Imaging of the Brain with PET. San Diego, CA: Academic Press. p 361-367.
13. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. 2001b. In vivo measurement of activated microglia in dementia. Lancet 358:461-467.
14. Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, Kreutzberg GW, Jones T, Banati RB. 2001c. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124:2014-2027.
15. Cahard D, Canat X, Carayon P, Roque C, Casellas P, Le Fur G. 1994. Subcellular localization of peripheral benzodiazepine receptors on human leukocytes. Lab Invest 70:23-28.
16. Chung YL, Williams A, Ritchie D, Williams SC, Changani KK, Hope J, Bell JD. 1999. Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. NeuroReport 10:3471-3477.
17. Conway EL, Gundlach AL, Craven JA. 1998. Temporal changes in glial fibrillary acidic protein messenger RNA and [3H] PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat. Neuroscience 82:805-817.
18. Cowey A, Stoerig P, Williams C. 1999. Variance in transneuronal retrograde ganglion cell degeneration in monkeys after removal of striate cortex: Effect of size of the cortical lesion. Vision Res 39:3642-3652.
19. Cremer JE, Hume SP, Cullen BM, Myers R, Manjil LG, Turton DR, Luthra SK, Bateman DM, Pike VW. 1992. The distribution of radioactivity in brains of rats given [N-methyl-11C]PK 11195 in vivo after induction of a cortical ischaemic lesion. Int J Radiat Appl Instrum B 19:159-166.
20. Diekmann S, Ohm TG, Nitsch R. 1996. Long-lasting transneuronal changes in rat dentate granule cell dendrites after entorhinal cortex lesion. A combined intracellular injection and electron microscopy study. Brain Pathol 6:205-214.
21. di Michele F, Lekieffre D, Pasini A, Bernardi G, Benavides J, Romeo E. 2000. Increased neurosteroids synthesis after brain and spinal cord injury in rats. Neurosci Lett 284:65-68.
22. Dubois A, Benavides J, Peny B, Duverger D, Fage D, Gotti B, MacKenzie ET, Scatton B. 1988. Imaging primary and secondary ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res 445:77-90.
23. Dumont F, De Vos F, Versijpt J, Jansen HM, Korf J, Dierckx RA, Slegers G. 1999. In vivo evaluation in mice and metabolism in blood of human volunteers of [123 I]iodo-PK11195: A possible single-photon emission tomography tracer for visualization of inflammation. Eur J Nucl Med 26:194-200.
24. Flugel A, Bradl M, Kreutzberg GW, Graeber MB. 2001. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J Neurosci Res 66:74-82.
25. Fuerst D, Shah J, Kupsky WJ, Johnson R, Shah A, Hayman-Abello B, Ergh T, Poore Q, Canady A, Watson C. 2001. Volumetric MRI, pathological, and neuropsychological progression in hippocampal sclerosis. Neurology 57:184-188.
26. Galiegue S, Jbilo O, Combes T, Bribes E, Carayon P, Le Fur G, Casellas P. 1999. Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem 274:2938-2952.
27. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. 1999. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629-650.
28. Ghetti B, Horoupian DS, Wisniewski HM. 1975. Acute and long-term transneuronal response of dendrites of lateral geniculate neurons following transection of the primary visual afferent pathway. Adv Neurol 12:401-424.
29. Giulian D, Corpuz M. 1993. Microglial secretion products and their impact on the nervous system. Adv Neurol 59:315-320.
30. Golani I, Weizman A, Leschiner S, Spanier I, Eckstein N, Limor R, Yanai J, Maaser K, Scherubl H, Weisinger G, Gavish M. 2001. Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry 40:10213-10222.
31. Graeber MB. 2001. Glial inflammation in neurodegenerative diseases. Immunology 101(suppl 1):52.
32. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. 1997. Parametric imaging of ligand receptor binding in PET using a simplified reference region model. Neuroimage 6:279-287.
33. Gunn RN, Lammerstma AA, Cunningham VJ. 1998. Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis. In: Carson R, Daule M, Witherspoon P, Herscovitch P, editors. Quantitative Functional Brain Imaging with Positron Emission Tomography. San Diego, CA: Academic Press. p 401-406.
34. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. 1999. Peripheral-type benzodiazepine receptor (PBR) in human breast tissue: Correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 59:831-842.
35. Hertz L. 1993. Binding characteristics of the receptor and coupling to transport proteins. In: Giessen-Crouse E, editor. Peripheral Benzodiazepine Receptors. London: Academic Press. p 27-51.
36. Hoff SF, Scheff SW, Kwan AY, Cotman CW. 1981. A new type of lesion-induced synaptogenesis: I. Synaptic turnover in non-denervated zones of the dentate gyrus in young adult rats. Brain Res 222:1-13.
37. Hunt JL, Winkelstein BA, Rutkowski MD, Weinstein JN, DeLeo JA. 2001. Repeated injury to the lumbar nerve roots produces enhanced mechanical allodynia and persistent spinal neuroinflammation. Spine 26:2073-2079.
38. in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH. 2001. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521.
39. Itzhak Y, Baker L, Norenberg MD. 1993. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: Evidence for multiplicity. Glia 9:211-218.
40. Johnson H, Cowey A. 2000. Transneuronal retrograde degeneration of retinal ganglion cells following restricted lesions of striate cortex in the monkey. Exp Brain Res 132:269-275.
41. Jones EG. 2000. Cortical and subcortical contributions to activity-dependent plasticity in primate somatosensory cortex. Annu Rev Neurosci 23: 1-37.
42. Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, McKeever PE, Wieland DM, Kilbourn MR, Starosta-Rubinstein S, et al. 1989. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 26:752-758.
43. Knecht S, Henningsen H, Hohling C, Elbert T, Flor H, Pantev C, Taub E. 1998. Plasticity of plasticity? Changes in the pattern of perceptual correlates of reorganization after amputation. Brain 121:717-724.
44. Kraepelin E. 1899. Psychiatrie. Lehrbuch für Studirende und Aerzte. Leipzig: Johann Ambrosius Barth.
45. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
46. Kuhlmann AC, Guilarte TR. 2000. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 4:1694-1704.
47. Kumlien E, Hilton-Brown P, Spannare B, Gillberg PG. 1992. In vitro quantitative autoradiography of [3H]-L-deprenyl and [3H]-PK 11195 binding sites in human epileptic hippocampus. Epilepsia 33:610-617.
48. Lacor P, Gandolfo P, Tonon MC, Brault E, Dalibert I, Schumacher M, Benavides J, Ferzaz B. 1999. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: A role for PBR in neurosteroidogenesis. Brain Res 815:70-80.
49. Lammertsma AA, Hume SP. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
50. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D. 1999. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598-605.
51. McGeer PL, McGeer EG. 1995. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195-218.
52. Myers R, Manjil LG, Cullen BM, Price GW, Frackowiak RSJ, Cremer JE. 1991a. Macrophage and astrocyte populations in relation to [3H] PK11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11:314-322.
53. Myers R, Manjil LG, Cullen BM, Price GW, Frackowiak RSJ, Cremer JE. 1991b. (3H) PK 11195 and the localisation of secondary thalamic lesions following focal ischemia in rat motor cortex. Neurosci Lett 133:20-24.
54. Myers R, Gunn RN, Cunningham VJ, Banati RB, Jones T. 1999. Cluster analysis and the reference tissue model in the analysis of clinical [11C](R)-PK11195 PET. J Cereb Blood Flow Metab 19(suppl):789.
55. Olson JM, Ciliax BJ, Mancini WR, Young AB. 1988. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur J Pharmacol 26:152:47-53.
56. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB. 2000. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C] PK11195. Neurology 55:1052-1054.
57. 18F) PK 14105 as markers for neuronal damage. J Neurochem 55:175-185.
58. Raivich G, Jones LL, Kloss CUA, Werner A, Neumann H, Kreutzberg GW. 1998. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sires of neuronal degeneration. J Neurosci 18:5804-5816.
59. Ramsay SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, Frackowiak RSJ. 1992. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 339:1054-1055.
60. Raghavendra Rao VL, Dogan A, Bowen KK, Dempsey RJ. 2000. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol 16:102-114.
61. Rovaris M, Fillipi M. 2000. Contrast enhancement and the acute lesion in multiple sclerosis. Neuroimag Clin North Am 10:705-716.
62. Sauvageau A, Desjardins P, Lozeva V, Rose C, Hazell AS, Bouthillier A, Butterworth RF. 2002. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: Implications for PET imaging of hippocampal sclerosis. Metab Brain Dis 17:3-11.
63. Schallert T, Leasure JL, Kolb B. 2000. Experience-associated structural events, subependymal cellular proliferative activity, and functional recovery after injury to the central nervous system. J Cereb Blood Flow Metab 20:1513-1528.
64. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barre L, Travere JM, Derlon JM, MacKenzie ET. 1993. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 24:2046-2057.
65. Shah F, Pike VW, Ashworth S, McDermott J. 1994. Synthesis of the enantiomer of [N-methyl-11C]PK11195 and comparison of their behaviours as PK (peripheral benzodiazepine) binding site radioligands in rats. Nucl Med Biol 21:573-581.
66. Sorensen JC, Dalmau I, Zimmer J, Finsen B. 1996. Microglial reactions to retrograde degeneration of racer-identified thalamic neurons after frontal sensorimotor cortex lesions in adult rats. Exp Brain Res 11:203-212.
67. Stephenson DT, Schober DA, Smalstig EB, Mincy RC, Gehlert DR, Clemens JA. 1995. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15:5263-5274.
68. Su JH, Deng G, Cotman CW. 1997. Transneuronal degeneration in the spread of Alzheimer's disease pathology: Immunohistochemical evidence for the transmission of tau hyperphosphorylation. Neurobiol Dis 4:365-375.
69. Sutula TP, Pitkänen A. 2001. More evidence for seizure-induced neuron loss. Is hippocampal sclerosis both cause and effect of epilepsy? Neurology 57:169-170.
70. Topper R, Gehrmann J, Schwarz M, Block F, Noth J, Kreutzberg GW. 1993. Remote microglial activation in the quinolinic acid model of Huntington's disease. Exp Neurol 123:271-283.
71. Wu YP, Ling EA. 1998. Transsynaptic changes of neurons and associated microglial reaction in the spinal cord of rats following middle cerebral artery occlusion. Neurosci Lett 256:41-44.
72. Yeo JF, Liu HP, Leong SK. 2001. Sustained microglial immunoreactivity in the caudal spinal trigeminal nucleus after formalin injection. J Dent Res 80:1524-1529.